The additional COVID-19 Lab that ARUP has reconstructed to help meet renewed demand performs automated COVID-19 testing by nucleic acid amplification on Roche instrumentation.
ARUP Laboratories has reconstructed an additional lab dedicated solely to high-throughput COVID-19 molecular diagnostic testing to meet renewed demand for testing.
ARUP Laboratories’ intentional design of environmentally friendly features in its new state-of-the-art laboratory facility has already paid off in the form of a large rebate
ARUP’s dedicated employees, including Brook Berger, a lab supervisor, make a difference in the lives of patients every day. A workplace culture that prioritizes patient care is among the strengths that landed ARUP on Forbes’ list of America’s Best Employers by State for 2021.
ARUP’s commitment to providing the best in patient care while also caring for the needs of its workforce has earned it a spot on the Forbes list of America's Best Employers
On a tour of ARUP’s state-of-the-art laboratory facility, Chief Operations Officer Jonathan Genzen, MD, PhD, explains to Rep. Burgess Owens, R-Utah, the role that automated sorters play in getting specimens through the laboratory to specific testing locations.
Utah Rep. Burgess Owens visited ARUP Laboratories as part of a BioUtah BioHive tour of homegrown companies that have put Utah on the map as the center of innovation in the life sciences industry.
An ARUP employee reviews the result of a test to detect the presence of ova or parasites in a specimen. ARUP and Techcyte collaborated in 2019 to produce the world’s first artificial intelligence (AI)-enabled detection tool, which helps laboratorians quickly screen out negative results so they can spend more time analyzing slides that show positive results.
ARUP announced an investment in Techcyte Inc. as part of the company’s new $21 million funding round. This will enable Techcyte to expand the development team for its digital diagnostics platform.
ARUP Laboratories’ inaugural Lab Leadership Symposium, “Creating Connections: Advancing Your Lab’s Value in the Healthcare System” will be held Thursday, October 21, 2021.
In a Clinical Laboratory News article he coauthored, ARUP Medical Director Brian Jackson, MD, describes how the COVID-19 pandemic has expanded access to testing services and created an opportunity for clinical laboratories to build on patient-centered lab stewardship.
Crisis often fuels innovation, and the COVID-19 pandemic has been no exception.
Sean McGary wasn’t sure what kind of career he wanted when he started at ARUP in an entry-level position. He just needed a reliable schedule with a stable company. Since then, McGary has consistently moved up into positions with more responsibility and increased pay.
The career growth spotlight series shows the myriad career paths possible at ARUP, inside and outside more than 65 laboratories and in more than 180 departments.
Students listen as automation engineer Darby Nelson (not pictured) shows how electricity and magnets can work together to levitate samples on these rectangular movers in order to avoid any friction, which decreases wear and tear on machinery.
Nearly 150 Native American middle-school children recently visited ARUP as part of an American Indian Services PREP Program that focuses on science, technology, engineering, and math (STEM) education.
ARUP has launched an enhanced MLS Faculty & Student Resource Center that provides free online materials to supplement and enrich medical laboratory science (MLS) students’ academic experience.
ARUP experts evaluated an Emergency Use Authorization assay that detects SARS-CoV-2 neutralizing antibodies such as those pictured.
A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.
ARUP is using Deep Bio’s artificial intelligence-based software in research to evaluate how use of the software may aid in detection and classification of prostate cancer cells, such as the cells pictured here.
Deep Bio announced a research collaboration agreement with ARUP Laboratories. Deep Bio’s AI-based prostate cancer diagnosis software will be used for the joint research.